Nomura Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
17,531
-42,392
-71% -$2.47M ﹤0.01% 1141
2025
Q4
$3.23M Sell
59,923
-225,160
-79% -$10.8M ﹤0.01% 931
2025
Q3
$12.9M Buy
285,083
+230,258
+420% +$10.8M 0.02% 443
2025
Q2
$2.54M Sell
54,825
-22,919
-29% -$1.13M 0.01% 775
2025
Q1
$4.74M Sell
77,744
-2,892
-4% -$169K 0.01% 730
2024
Q4
$4.56M Buy
80,636
+41,644
+107% +$2.33M 0.01% 806
2024
Q3
$2.02M Sell
38,992
-43,736
-53% -$2.05M ﹤0.01% 945
2024
Q2
$3.44M Buy
82,728
+25,371
+44% +$1.14M 0.01% 760
2024
Q1
$3.11M Sell
57,357
-23,446
-29% -$1.19M 0.01% 769
2023
Q4
$4.15M Buy
80,803
+1,572
+2% +$82.5K 0.01% 728
2023
Q3
$4.6M Buy
79,231
+33,446
+73% +$2.05M 0.01% 564
2023
Q2
$2.93M Buy
+45,785
New +$3.07M 0.01% 635
2023
Q1
Sell
-622,966
Closed -$43.1M 1474
2022
Q4
$43.1M Buy
622,966
+528,135
+557% +$39.8M 0.18% 118
2022
Q3
$6.49M Buy
94,831
+71,316
+303% +$5.17M 0.03% 461
2022
Q2
$1.72M Sell
23,515
-319,608
-93% -$24.3M 0.01% 834
2022
Q1
$24.2M Buy
343,123
+118,534
+53% +$7.96M 0.07% 161
2021
Q4
$13.5M Buy
224,589
+88,317
+65% +$5.18M 0.03% 377
2021
Q3
$7.94M Buy
136,272
+11,440
+9% +$753K 0.02% 483
2021
Q2
$8.05M Sell
124,832
-13,558
-10% -$884K 0.02% 443
2021
Q1
$8.46M Sell
138,390
-95,607
-41% -$5.95M 0.02% 394
2020
Q4
$14.1M Buy
233,997
+193,237
+474% +$11.9M 0.02% 351
2020
Q3
$2.39M Sell
40,760
-39,098
-49% -$2.35M 0.01% 625
2020
Q2
$4.57M Buy
79,858
+5,782
+8% +$346K 0.02% 402
2020
Q1
$4.04M Sell
74,076
-367,502
-83% -$22.5M 0.02% 353
2019
Q4
$27.3M Buy
441,578
+329,551
+294% +$18.9M 0.1% 153
2019
Q3
$5.6M Sell
112,027
-159,996
-59% -$7.52M 0.02% 442
2019
Q2
$12.5M Sell
272,023
-2,539,052
-90% -$118M 0.06% 276
2019
Q1
$133M Buy
2,811,075
+2,805,995
+55,236% +$140M 0.56% 28
2018
Q4
$262K Buy
5,080
+933
+22% +$50.1K ﹤0.01% 1054
2018
Q3
$257K Sell
4,147
-27,294
-87% -$1.62M ﹤0.01% 1124
2018
Q2
$1.74M Sell
31,441
-340,985
-92% -$18.4M 0.01% 766
2018
Q1
$23.5K Sell
372,426
-77,126
-17% -$4.96M 0.04% 224
2017
Q4
$27.5M Sell
449,552
-57,355
-11% -$3.59M 0.05% 226
2017
Q3
$32.1M Buy
506,907
+190,784
+60% +$11.1M 0.07% 171
2017
Q2
$17.6M Buy
316,123
+127,878
+68% +$6.96M 0.04% 221
2017
Q1
$10.3M Sell
188,245
-17,860
-9% -$980K 0.03% 296
2016
Q4
$12.1M Buy
206,105
+159,949
+347% +$8.74M 0.03% 327
2016
Q3
$2.51M Buy
+46,156
New +$2.96M 0.01% 624
2016
Q2
Sell
-53,564
Closed -$3.78M 1261
2016
Q1
$3.41M Sell
53,564
-4,681
-8% -$295K 0.01% 449
2015
Q4
$4.01M Buy
58,245
+40,399
+226% +$2.67M 0.01% 452
2015
Q3
$1.05M Sell
17,846
-81,527
-82% -$5.17M ﹤0.01% 733
2015
Q2
$6.49M Buy
99,373
+85,740
+629% +$5.65M 0.02% 369
2015
Q1
$865K Sell
13,633
-159,410
-92% -$9.98M ﹤0.01% 870
2014
Q4
$10.1M Buy
173,043
+116,893
+208% +$6.59M 0.03% 354
2014
Q3
$2.87M Sell
56,150
-60,760
-52% -$3.04M 0.01% 925
2014
Q2
$5.68M Sell
116,910
-217,182
-65% -$10.7M ﹤0.01% 619
2014
Q1
$17.4M Buy
334,092
+216,571
+184% +$11.5M 0.01% 321
2013
Q4
$6.24M Sell
117,521
-165,005
-58% -$8.41M 0.03% 334
2013
Q3
$13.1M Buy
282,526
+105,024
+59% +$4.61M 0.08% 190
2013
Q2
$7.96M Buy
+177,502
New +$7.71M 0.06% 212

Other funds holding BMY

Nomura Holdings's BMY Position: Q1 2026 in Review

Nomura Holdings reduced its Bristol-Myers Squibb (BMY) stake by 71% in Q1 2026, selling an estimated $2.47M and leaving 17,531 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

Nomura Holdings first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $133M in Q1 2019. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Nomura Holdings held 17,531 shares of Bristol-Myers Squibb worth $1.06M as of Q1 2026.
  • Nomura Holdings sold 42,392 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.47M.
  • Bristol-Myers Squibb made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1141 holding.
  • Nomura Holdings first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
  • Nomura Holdings's Bristol-Myers Squibb position peaked at $133M in Q1 2019.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.